The ultimate aim of the Platform's work is to translate its research to the clinic. A quick arrival of nanomedicine to the patient requires building early bridges between clinical research and academy and industry, to exchange knowledge and to identify the cases in which the added value of nanodrugs and nanodiagnostics may turn out to be particularly useful.

See Hospitals >>>